E-RARE - à projets pour la recherche sur les maladies rares
Gene Therapy for Cerebellar Ataxias: restoring cholesterol metabolism by targeting brain cholesterol 24 hydroxylase (CYP46A1) – SCA-CYP
Project coordination
Nathalie Cartier (Thérapie génique, Génétique, Epigénétique en neurologie, endocrinologie et développement)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
INSERM U1169 Thérapie génique, Génétique, Epigénétique en neurologie, endocrinologie et développement
ICM ICM
Help of the ANR 494,700 euros
Beginning and duration of the scientific project:
May 2018
- 36 Months
